Geron Corp (GERN) Files 8-K with Financials
Ticker: GERN · Form: 8-K · Filed: Mar 19, 2024 · CIK: 886744
| Field | Detail |
|---|---|
| Company | Geron Corp (GERN) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, sec-filing
Related Tickers: GERN
TL;DR
GERN filed an 8-K with financial statements and exhibits, no major news.
AI Summary
On March 19, 2024, Geron Corporation (GERN) filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or other significant business updates detailed in the provided text. The report confirms Geron's corporate information and filing details.
Why It Matters
This filing provides routine updates on Geron Corporation's financial statements and exhibits, which are important for investors to track the company's financial health and reporting compliance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report containing financial statements and exhibits, with no indication of significant new risks or material adverse events.
Key Players & Entities
- GERON CORP (company) — Registrant
- 0000886744 (company) — Central Index Key
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
- 752287752 (company) — IRS Number
- DE (company) — State of Incorporation
- 1231 (company) — Fiscal Year End
- 919 EAST HILLSDALE BOULEVARD (company) — Business Address Street 1
- SUITE 250 (company) — Business Address Street 2
- FOSTER CITY (company) — Business Address City
- CA (company) — Business Address State
FAQ
What is the primary purpose of this 8-K filing by Geron Corporation?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of March 19, 2024.
What is Geron Corporation's Standard Industrial Classification (SIC) code?
Geron Corporation's Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Geron Corporation's principal executive office located?
Geron Corporation's principal executive office is located at 919 E. Hillsdale Blvd., Suite 250, Foster City, California 94404.
What is the fiscal year end for Geron Corporation?
Geron Corporation's fiscal year ends on December 31st (1231).
What is the SEC file number for Geron Corporation?
Geron Corporation's SEC file number is 000-20859.
Filing Stats: 517 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-03-19 06:30:30
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value GERN The Nasdaq Stock Mar
Filing Documents
- gern-20240318.htm (8-K) — 42KB
- gern-ex99_1.htm (EX-99.1) — 502KB
- gern-ex99_2.htm (EX-99.2) — 44KB
- gern-ex99_2s1.jpg (GRAPHIC) — 327KB
- gern-ex99_2s2.jpg (GRAPHIC) — 1123KB
- gern-ex99_2s3.jpg (GRAPHIC) — 532KB
- gern-ex99_2s4.jpg (GRAPHIC) — 438KB
- gern-ex99_2s5.jpg (GRAPHIC) — 545KB
- gern-ex99_2s6.jpg (GRAPHIC) — 205KB
- gern-ex99_2s7.jpg (GRAPHIC) — 420KB
- gern-ex99_2s8.jpg (GRAPHIC) — 477KB
- gern-ex99_2s9.jpg (GRAPHIC) — 474KB
- gern-ex99_2s10.jpg (GRAPHIC) — 387KB
- gern-ex99_2s11.jpg (GRAPHIC) — 445KB
- gern-ex99_2s12.jpg (GRAPHIC) — 399KB
- gern-ex99_2s13.jpg (GRAPHIC) — 402KB
- gern-ex99_2s14.jpg (GRAPHIC) — 369KB
- gern-ex99_2s15.jpg (GRAPHIC) — 452KB
- gern-ex99_2s16.jpg (GRAPHIC) — 478KB
- gern-ex99_2s17.jpg (GRAPHIC) — 548KB
- gern-ex99_2s18.jpg (GRAPHIC) — 397KB
- gern-ex99_2s19.jpg (GRAPHIC) — 605KB
- gern-ex99_2s20.jpg (GRAPHIC) — 443KB
- gern-ex99_2s21.jpg (GRAPHIC) — 453KB
- gern-ex99_2s22.jpg (GRAPHIC) — 450KB
- gern-ex99_2s23.jpg (GRAPHIC) — 170KB
- gern-ex99_2s24.jpg (GRAPHIC) — 452KB
- gern-ex99_2s25.jpg (GRAPHIC) — 423KB
- gern-ex99_2s26.jpg (GRAPHIC) — 334KB
- gern-ex99_2s27.jpg (GRAPHIC) — 478KB
- gern-ex99_2s28.jpg (GRAPHIC) — 442KB
- gern-ex99_2s29.jpg (GRAPHIC) — 128KB
- gern-ex99_2s30.jpg (GRAPHIC) — 405KB
- gern-ex99_2s31.jpg (GRAPHIC) — 536KB
- gern-ex99_2s32.jpg (GRAPHIC) — 158KB
- gern-ex99_2s33.jpg (GRAPHIC) — 537KB
- 0000950170-24-033142.txt ( ) — 20671KB
- gern-20240318.xsd (EX-101.SCH) — 27KB
- gern-20240318_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. Geron Corporation (the "Company") is updating certain disclosures about the risk factors applicable to its business contained in its prior public filings, including those discussed under the heading "Item 1A. Risk Factors" in its Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on February 28, 2024. The updated description of the Company's risk factors is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. On March 19, 2024, the Company made available an updated corporate presentation on the Company's website. A copy of the corporate presentation is filed herewith as Exhibit 99.2 and incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Updated Risk Factors 99.2 Corporate Presentation, dated March 2024 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GERON CORPORATION Date: March 19, 2024 By:/s/ Scott A. Samuels Scott A. Samuels Executive Vice President, Chief Legal Officer and Corporate Secretary 2